Claim and evidence Close ×
The Office of the Assistant Secretary for Preparedness and Response published a proposed revised screening framework guidance for providers and users of synthetic oligonucleotides in the Federal Register of 29 April 2022, submitting it for public consideration and comment for a period of 60 days. Copy claim link
Copy claim reference
Machine-checked, not reviewed by an editor Stated in source Supported
Supporting evidence: primary · 1 source
Object version As published in the Federal Register of 29 April 2022 (87 FR 25495) · Published 2022-04-29 · Effective date not established Date 2022-04-29 · publication Scope and limits Records the publication of a proposed draft and its stated comment period. A draft is not guidance in force; the notice states that the interagency process was still considering whether to issue the revised guidance as final. The comments received are not recorded. The notice of April 2022 prints the submitting body as the Office of the Assistant Secretary for Preparedness and Response, and the statement uses that name (cross-family check, item 26). The dataset entity carries the later Administration name, which the 2023 notice and the component’s current pages use; no text stating a renaming was retrieved, so no dated name is recorded and the question is listed in the admission record.
The evidence 02 primary source Supports the claim
Screening Framework Guidance for Providers and Users of Synthetic Oligonucleotides (87 FR 25495) ↗ Federal Register (Office of the Federal Register, National Archives) via govinfo.gov · Publication date unknown
Copy source reference
Cite the original source Cite the original document, not Selekoa. Check these details against it.
Copy APA
Download BibTeX Download RIS Download CSL-JSON
Source excerpt “is submitting this Revised Guidance for public consideration and comment for a period of 60 days” Location in source Request for Comments, 87 FR 25495
How it was read Retrieved directly from the publisher
Machine-checked · 2026-10-30
Source details and check notes Authors Federal Register (Office of the Federal Register, National Archives) via govinfo.gov Version Retrieved for the candidate pack on 2026-10-28 (SHA-256 57b028801e628b4ba88d1b97b08f9a29e01478a1d905845db087cbb3e06fdd99). Federal Register print of 29 April 2022, Vol. 87, No. 83, FR Doc. 2022-09210: the proposed draft revised guidance published for comment. Retrieved again at admission on 2026-10-30 (SHA-256 57b028801e628b4ba88d1b97b08f9a29e01478a1d905845db087cbb3e06fdd99, the same bytes). Canonical address Open the canonical source ↗ Accessed 2026-10-28 Language English (en) Attribution Federal Register (Office of the Federal Register, National Archives) via govinfo.gov, “Screening Framework Guidance for Providers and Users of Synthetic Oligonucleotides (87 FR 25495)”. Reuse No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution. Check notes Candidate pack passage, AI and biosecurity (research/ai-bio). The quotation (16 words) matched the text retrieved for the candidate pack on 2026-10-28 and again at admission on 2026-10-30, in a fresh retrieval whose SHA-256 equals the pack’s. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. The sentence names the Office of the Assistant Secretary for Preparedness and Response within HHS as the submitter. A cross-family machine check (2026-10-30, item 26) answered the record’s question blind from fresh retrievals and agreed in part; its corrections were applied at admission. No human editorial review. primary source Supports the claim
Screening Framework Guidance for Providers and Users of Synthetic Oligonucleotides (87 FR 25495) ↗ Federal Register (Office of the Federal Register, National Archives) via govinfo.gov · Publication date unknown
Copy source reference
Cite the original source Cite the original document, not Selekoa. Check these details against it.
Copy APA
Download BibTeX Download RIS Download CSL-JSON
Source excerpt “ASPR is the lead agency in a broad interagency process considering possible changes to the Guidance and whether to issue the proposed Revised Guidance as final guidance.” Location in source Request for Comments, 87 FR 25495
How it was read Retrieved directly from the publisher
Machine-checked · 2026-10-30
Source details and check notes Authors Federal Register (Office of the Federal Register, National Archives) via govinfo.gov Version Retrieved for the candidate pack on 2026-10-28 (SHA-256 57b028801e628b4ba88d1b97b08f9a29e01478a1d905845db087cbb3e06fdd99). Federal Register print of 29 April 2022, Vol. 87, No. 83, FR Doc. 2022-09210: the proposed draft revised guidance published for comment. Retrieved again at admission on 2026-10-30 (SHA-256 57b028801e628b4ba88d1b97b08f9a29e01478a1d905845db087cbb3e06fdd99, the same bytes). Canonical address Open the canonical source ↗ Accessed 2026-10-28 Language English (en) Attribution Federal Register (Office of the Federal Register, National Archives) via govinfo.gov, “Screening Framework Guidance for Providers and Users of Synthetic Oligonucleotides (87 FR 25495)”. Reuse No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution. Check notes Candidate pack passage, AI and biosecurity (research/ai-bio). The quotation (27 words) matched the text retrieved for the candidate pack on 2026-10-28 and again at admission on 2026-10-30, in a fresh retrieval whose SHA-256 equals the pack’s. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. A cross-family machine check (2026-10-30, item 26) answered the record’s question blind from fresh retrievals and agreed in part; its corrections were applied at admission. No human editorial review. Status and meaning Editorial status. Not reviewed by an editor . An exploratory record that no editor has accepted. This status does not say whether a person has read any linked passage. Each evidence record above shows how it was checked.
Relation. Publication of a specific document or version. Publication of a policy is not evidence of implementation.
Date. Federal Register issue of 29 April 2022 (87 FR 25495).
Record ID ab-scr-hhs-2022-draft-published